Suomen Bioanalytiikka Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $1.95M
Latest Deal Amount

Suomen Bioanalytiikka General Information

Description

Developer of products for diagnostics and research of bone diseases. The company develops novel immunoassays for bone-metabolism studies and diagnostics. Its products include the BoneTRAP kit for detection of bone metastasis and follow-up of osteoporosis treatment.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Primary Office
  • Tykistokatu 6 B 3
  • BioCity
  • 20520 Turku
  • Finland
+358 02 0000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Suomen Bioanalytiikka Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 21-Feb-2005 $1.95M 00.000 Completed Generating Revenue
1. Early Stage VC 15-Mar-2001 Completed Product Development
To view Suomen Bioanalytiikka’s complete valuation and funding history, request access »

Suomen Bioanalytiikka Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Argentum Fondsinvesteringer PE/Buyout Minority 000 0000 000000 0
Teknoventure Venture Capital Minority 000 0000 000000 0
To view Suomen Bioanalytiikka’s complete investors history, request access »